The onconeuronal cerebellar degeneration-related antigen Cdr2 is associated with paraneoplastic syndromes. Neoplastic expression of Cdr2 in ovary and breast tumors triggers an autoimmune response that suppresses tumor growth by developing tumor immunity, but culminates in cerebellar degeneration when Cdr2-specific immune cells recognize neuronal Cdr2. We identified Cdr2 as a novel interactor of the hypoxia-inducible factor (HIF) prolyl-4-hydroxylase PHD1 and provide evidence that Cdr2 might represent a novel important tumor antigen in renal cancer. Strong Cdr2 protein expression was observed in 54.2% of papillary renal cell carcinoma (pRCC) compared with 7.8% of clear-cell RCC and no staining was observed in chromophobe RCC or oncocytoma. High Cdr2 protein levels correlated with attenuated HIF target gene expression in these solid tumors, and Cdr2 overexpression in tumor cell lines reduced HIF-dependent transcriptional regulation. This effect was because of both attenuation of hypoxic protein accumulation and suppression of the transactivation activity of HIF-1a. pRCC is known for its tendency to avascularity, usually associated with a lower pathological stage and higher survival rates. We provide evidence that Cdr2 protein strongly accumulates in pRCC, attenuates the HIF response to tumor hypoxia and may become of diagnostic importance as novel renal tumor marker.
Introduction
Hypoxia is a characteristic feature of the microenvironment of many tumor types, and contributes to malignant tumor behavior associated with therapy resistance and poor prognosis (Brown and Wilson, 2004; Pouysse´gur et al., 2006) . Heterodimeric hypoxiainducible transcription factors (HIFs) are master regulators of oxygen homeostasis and many HIF target genes are involved in adaptive changes of cancer cells to their hypoxic microenvironment (Wenger, 2002; Wenger et al., 2005) . On the molecular level, cells sense alterations in oxygen levels by oxygen-dependent HIF prolyl and asparaginyl hydroxylation, which determines HIF-a protein stability and transactivation activity, respectively. Oxygen-dependent hydroxylation of two distinct HIF-a prolyl residues by the three HIF prolyl-4-hydroxylase domain proteins, PHD1, 2 and 3 (alternatively termed HPH3/EGLN2, HPH2/EGLN1 and HPH1/EGLN3, respectively), is necessary for the interaction with the von Hippel-Lindau tumor suppressor protein (pVHL) that serves as a recognition unit of a multiprotein ubiquitin E3 ligase and targets HIF-a for proteasomal degradation (Maxwell et al., 1999; Bruick and McKnight, 2001; Epstein et al., 2001; Jaakkola et al., 2001; Ivan et al., 2002) . Compared with collagen prolyl-4-hydroxylase and mitochondrial cytochrome c oxidase, PHDs have a lower O 2 affinity that suits these enzymes to regulate HIF-a protein levels in response to a wide range of physiologically relevant pO 2 (Schofield and Ratcliffe, 2004) . Hydroxylation of an asparaginyl residue in the transactivation domain of HIF-a by factor inhibiting HIF (FIH) blocks the interaction with the transcriptional co-activator p300 and thus impairs the induction of target genes by regulating the transactivation activity of HIF (Mahon et al., 2001) .
Importantly, mass spectroscopic evidence for hydroxylation of ankyrin repeats in IkB and nuclear factor kB family members, as well as in ASB4, a suppressor of cytokine signaling, by FIH showed that hydroxylation is not restricted to HIF-a subunits (Coleman et al., 2007; Ferguson et al., 2007) . Although direct mass spectroscopic evidence for hydroxylation is missing, PHD1 and PHD3 have recently been shown to regulate IkB kinase-b and activating transcription factor-4, respectively (Cummins et al., 2006; Koditz et al., 2007) . Apart from mediating HIF-a protein stability, these data indicate that PHDs might regulate additional oxygen-dependent signaling pathways. We identified cerebellar degeneration-related protein 2 (Cdr2) as novel PHD1-interacting partner, and comprehensive analysis on tissues and tumor cell lines showed that abundant Cdr2 protein levels are a characteristic feature of papillary renal cell carcinoma (pRCC) and might lead to attenuated hypoxic response pathways in these tumors.
Results
Onconeural antigen Cdr2 interacts with PHD1, but is oxygen-independently regulated PHD1 was expressed as fusion protein with G4-DBD (Gal4 DNA-binding domain) or LexA as bait in two independent yeast two-hybrid screenings of mouse and human testis cDNA libraries. Two mouse Cdr2 clones (accession number NM_007672) and a human Cdr2 cDNA clone (accession number NM_001802) were identified. No interaction was observed between Cdr2 and PHD2 or PHD3 in yeast (data not shown). The Cdr2:PHD1 interaction was confirmed in a mammalian system by transient transfection of HeLa cells with V5-tagged Cdr2 and myc-tagged PHD1 followed by coimmunoprecipitation ( Figure 1a) . Additional co-immunoprecipitation experiments with Cdr2 deletion constructs showed that PHD1 interacts with the N-terminal residues 1-208 of Cdr2 (data not shown).
To investigate whether the Cdr2:PHD1 interaction is oxygen-dependent, we expressed PHD1 fused to the G4-DBD together with the VP16-AD (VP16 activation domain) fused to Cdr2 in a mammalian two-hybrid system. As shown in Figure 1b , luciferase expression was significantly higher when the DBD-PHD1 and AD-Cdr2 fusion constructs were co-transfected than in transfections of either construct alone. In contrast to the significantly increased luciferase activity under hypoxic conditions after co-transfection of the positive control DBD-PHD1 with AD-HIF-1a, luciferase expression remained unchanged after co-transfection of DBD-PHD1 with ADCdr2 under hypoxic conditions compared with that under normoxic conditions. Although all three PHD isoforms interacted with HIF-1a, strong luciferase expression was only observed when Cdr2 was co-transfected with PHD1. Normoxic luciferase activities of the positive controls are low, as AD-HIF-1a is constantly degraded.
PHD1 and Cdr2 were ubiquitously expressed in adult mouse tissues with most abundant mRNA levels in the testis (Supplementary Figure S1 ). To investigate whether Cdr2 gene expression is oxygen-dependently regulated by HIF-1, we analysed Cdr2 mRNA levels in mouse embryonic fibroblasts (MEFs), either wild type (Hif1a
) for HIF-1a (Figure 1c ). Cdr2 mRNA levels were not regulated in a HIF-1a-dependent manner under hypoxic conditions, whereas transcription of the known HIF target gene N-myc downstream regulated gene 1 was induced. These results suggest that the Cdr2 gene is neither a HIF target nor is Cdr2 transcription oxygen-dependently regulated in MEF cells. In addition, no oxygen-dependent transcriptional regulation of Cdr2 was observed in cervical HeLa, ovary SKOV3 and OVCAR3 adenocarcinoma cells, breast BT474 and colorectal HCT116 carcinoma tumor cells (data not shown).
Even though Cdr2 mRNA is ubiquitously expressed, the only tissues reported to express Cdr2 protein are brain and testis, as well as gynecological and breast tumors, indicating that Cdr2 is regulated at a posttranscriptional level (Corradi et al., 1997; Darnell et al., 2000) . To investigate a possible Cdr2 protein regulation by PHD1, we generated monoclonal antibodies (mAb) against Cdr2 (Supplementary Figure S2) . To this end, MBP-Cdr2 fusion protein was expressed in Escherichia coli, affinity purified and used for the immunization of mice. Hybridoma supernatants were tested for the presence of anti-Cdr2 antibodies and one clone (mAb33), recognizing MBP-Cdr2 fusion protein as well as transfected Cdr2 by immunoblotting, was obtained (Supplementary Figure S2a) . Neither mouse Cdr2 nor human Cdr3 was recognized by mAb33 (Supplementary Figure S2b) . Importantly, mAb33 recognized endogenous Cdr2 in ovary SKOV3 cells and the specificity of the Cdr2 signal was confirmed by RNA interferencemediated downregulation of Cdr2 gene expression (Supplementary Figure S2c) . Anti-Cdr2 antibodies recognized two bands, running at B62 and B55 kDa, in cell lines as well as in in vitro transcription and translation experiments, suggesting that Cdr2 is post-translationally modified. Surprisingly, whereas the majority of ovary tumor tissues has been shown to react with paraneoplastic cerebellar degeneration patient sera , Cdr2 protein abundance in normoxic breast carcinoma cell lines, MCF-7 and BT474, as well as in cervical HeLa, colorectal HCT116, hepatoma HepG2 and osteosarcoma U2-OS tumor cell lines was comparable with ovary adenocarcinoma SKOV3 and OVCAR3 cell lines (Supplementary Figure S2d) .
To investigate whether O 2 -dependent PHD activity is involved in the regulation of endogenous Cdr2 protein levels, we cultured ovary carcinoma SKOV3 cells under normoxic or hypoxic conditions, or in the presence of the PHD inhibitor, dimethyloxalylglycine. Although HIF-1a protein strongly accumulated under hypoxic conditions and by PHD inhibition, endogenous Cdr2 protein abundance remained unaffected under these conditions (Figure 1d ). We tested seven additional cell lines (HeLa, OVCAR3, MCF-7, BT474, HCT116, HepG2 and U2-OS) as well as anoxia and anoxia/ reoxygenation conditions, but found no evidence for PHD-dependent and/or O 2 -dependent Cdr2 protein regulation (data not shown).
Papillary renal cell carcinoma expresses high Cdr2 protein levels and show attenuated expression of HIF-target genes To analyse Cdr2 protein levels in human tumors, we performed immunohistochemistry analysis on 162 benign and malignant specimens of 20 different organs and 12 distinct cell lines using tissue microarray (TMA) technology (Kononen et al., 1998; Struckmann et al., 2008) . As expected, Cdr2 staining was observed in brain, as well as in testis samples, and somewhat weaker in breast and ovary tumors, but quite surprisingly, the most intense Cdr2 protein signals were found in RCC (data not shown). Subsequent analysis of a TMA containing 384 RCC and normal kidney samples revealed a significant difference (Po0.001) in Cdr2 expression between histological RCC subtypes. Cdr2 protein expression was strongest in pRCC compared with clear cell (cc) and chromophobe RCC or benign oncocytoma (Table 1 and Figures 2a-c) . No difference in Cdr2 protein levels was observed between type 1 and type 2 pRCC (data not shown). Owing to the lack of high-quality anti-PHD1 antibodies, we were not successful in analysing PHD1 protein expression in these human tumor samples. Reverse transcriptase quantitative PCR analysis of renal cancer samples from TMA showed that Cdr2 transcript levels were slightly reduced in pRCC than in normal kidney, despite the very strong Cdr2 protein staining in pRCC (Figure 2d ). Cdr2 mRNA levels were even more decreased in ccRCC (Figure 2e ). Although PHD1 and PHD2 mRNA levels were slightly reduced in pRCC and ccRCC compared with those in normal kidney, induction of the HIF target genes, PHD3, VEGF and CAIX, by tumor hypoxia was þ / þ and Hif1a À/À MEFs were cultured under normoxic (20% O 2 ) or hypoxic (2% O 2 ) conditions. Total RNA was extracted at indicated time points and mRNA levels of Cdr2, NDRG1 and ribosomal S12 were quantified by reverse transcriptase-quantitative PCR. Transcript levels were normalized to S12 mRNA. (d) Ovary SKOV3 carcinoma cells were cultured under normoxic (20% O 2 ) or hypoxic (0.2% O 2 ) conditions, or in the presence of 1 mM dimethyloxalylglycine for 16 h. Whole cell extracts were analysed by immunoblotting using anti-Cdr2 (mAb33), anti-HIF-1a and anti-b-actin antibodies.
Cdr2 suppresses HIF function in papillary RCC
K Balamurugan et al strongly reduced in pRCC compared with ccRCC (Figures 2d and e). HIF-1a and HIF-2a mRNA levels were comparable in pRCC and ccRCC. However, in contrast to ccRCC, in which over 50% of the tumor samples showed positive HIF-1a protein staining as expected, all pRCC were HIF-1a negative, and decreased vascularization in pRCC compared with clear-cell and chromophobe RCC or oncocytoma was evident by reduced CD34 staining (data not shown).
Regulation of Cdr2 protein expression was VHLindependent (Supplementary Figure S3) . In addition, normal kidney, pRCC and ccRCC tissues were analysed for Cdr2 protein expression by immunoblotting Cdr2 suppresses HIF function in papillary RCC K Balamurugan et al ( Figure 2f ). Relative to normal kidney samples, Cdr2 protein levels were increased in pRCC and decreased in ccRCC, comparable to the TMA staining. Interestingly, additional faster migrating bands were detected in pRCC samples and it remains to be investigated whether Cdr2 is alternatively spliced or proteolytically processed in pRCC.
Cdr2 attenuates HIF-dependent transcriptional regulation
As neither Cdr2 gene expression nor protein abundance was regulated by HIF or PHD function, we next sought to investigate whether Cdr2 itself influences HIFdependent gene regulation in tumor cells. Therefore, HeLa cells were transiently co-transfected with increasing amounts of Cdr2 or control lacZ expression vectors, together with the HIF-dependent, HRE-driven reporter gene plasmid, pH3SVL, and a Renilla luciferase control plasmid. Notably, hypoxic luciferase activity was significantly reduced by Cdr2 overexpression compared with control transfections in a concentration-dependent manner (Figure 3a) .
To determine whether attenuation of HIF-dependent gene activity by Cdr2 overexpression depends on the presence of functional HREs, we transiently co-transfected Cdr2 and HIF-dependent reporter gene constructs harboring either wild type or mutated HREs from the transferrin enhancer. PHD2 overexpression was used as control. As shown in Figure 3b , significant suppression of hypoxic reporter gene activity by Cdr2 overexpression was dependent on functional HREs. The fact that attenuating effects of Cdr2 are specific to HIF function could be confirmed by measuring HIF-dependent reporter gene activity in MEFs either deficient for HIF-1a (Hif1a À/À ) or transiently reconstituted with a HIF-1a expression plasmid (data not shown).
To analyse the role of Cdr2 in the transcriptional regulation of HIF-dependent genes in a HIF-1a wildtype background, total RNA was isolated from cells transiently transfected with lacZ, PHD2 or Cdr2, and cultured under normoxic or hypoxic conditions. Analysis of transcript levels of CAIX, VEGF, GLUT1 and PHD3 showed that expression of these genes was induced by hypoxia as expected, but attenuated by Cdr2 overexpression (Figure 3c ). These data suggest that exogenous Cdr2 overexpression leads to a suppressed hypoxic induction of HIF target genes. In contrast, transcript levels of GLUT1, CAIX, PHD2 and PHD3 were not regulated under hypoxic conditions, or by overexpression of PHD2 or Cdr2 in Hif1a À/À MEFs (Supplementary Figure S4a) . Notably, transient reconstitution of HIF-1a in these cells partially restored hypoxic induction of HIF-dependent reporter activity and the inhibitory effect mediated by Cdr2 overexpression (Supplementary Figure S4b) . Quantification of HIF-1a, HIF-2a and ARNT mRNA levels revealed no regulation by Cdr2 overexpression, indicating that attenuation of HIF-dependent transcriptional regulation is not at the mRNA level (Supplementary Figure S4c) . Furthermore, small interfering RNA (siRNA)-mediated Cdr2 downregulation was used to evaluate whether modulation of endogenous Cdr2 gene expression affects HIF-dependent reporter gene activity. Compared with control siRNA transfection, HIFdependent luciferase activity was significantly increased by Cdr2 depletion (Figure 3d ). PHD2 downregulation served as positive control and resulted in scarcely detectable normoxic HIF-1a protein levels. Immunoblot analysis was not sensitive enough to detect normoxic HIF-1a under Cdr2 RNA interference conditions. Neither PHD2 nor Cdr2 downregulation increased HIF-dependent luciferase activity under hypoxic conditions (data not shown).
Cdr2 decreases hypoxic HIF-1a accumulation and modulates PHD1 protein levels We analysed whether Cdr2 overexpression influences hypoxically stabilized HIF-1a protein levels. As shown in Figure 4a , overexpression of Cdr2 reduced hypoxic HIF-1a protein accumulation in a dose-dependent manner. To explore the concomitant role of Cdr2 and PHD1 in the negative regulation of HIF-1a stability and/or transactivation activity, we co-transfected pH3SVL and control pRL-SV40 reporter vectors together with Cdr2 and/or PHD1 expression plasmids. Hypoxic induction of HIF-dependent reporter gene activity was reduced by exogenous Cdr2 or PHD1 expression, and an even stronger attenuation was observed when Cdr2 and PHD1 were co-overexpressed (Figure 4b ). Strikingly, increased PHD1 protein levels were observed when Cdr2 was concomitantly transfected, and immunoblot analysis of hypoxic endogenous HIF-1a protein accumulation under Cdr2 and PHD1 overexpression conditions showed that HIF-1a protein abundance was more efficiently reduced than in Cdr2 or PHD1 expression alone (Figure 4b ). Similar to the human pRCC samples, endogenous PHD1 mRNA levels were not affected by Cdr2 overexpression, suggesting that increased PHD1 protein levels result from a post-transcriptional mechanism (data not shown).
Next, we investigated the effect of concomitant endogenous Cdr2 downregulation and myc-tagged PHD1 overexpression on HIF-dependent reporter gene activity (Figure 4c ). HIF-dependent luciferase activity was significantly augmented by Cdr2 siRNA, whereas it was reduced by V5-Cdr2 overexpression, confirming the results in Figures 3d and a, respectively. In addition, Cdr2 siRNA-mediated elevated luciferase activity was significantly reduced by overexpression of increasing amounts of myc-PHD1 under normoxic, as well as hypoxic conditions, and repression of HIF-dependent luciferase activity under hypoxic conditions by myc-PHD1 expression was even more pronounced when V5-Cdr2 was co-transfected. Consistent with increased myc-PHD1 protein levels under Cdr2 overexpression conditions (Figure 4b ), downregulation of endogenous Cdr2 prominently reduced myc-PHD1 protein abundance under normoxic and hypoxic conditions (compare Figure 4c ), further suggesting a regulation of PHD1 protein abundance by Cdr2.
To investigate whether Cdr2-mediated suppression of hypoxic HIF activity is dependent on PHD1, we cotransfected pH3SVL reporter vector together with Cdr2 and/or PHD1 expression plasmids in PHD1-deficient (Phd1 À/À ) MEFs. Indeed, whereas Cdr2 overexpression alone weakly increased HIF-dependent reporter gene activity, Cdr2 reduced relative luciferase activity when co-transfected together with PHD1, suggesting that the or hypoxic (closed bars) conditions for 16 h. Total RNA was extracted and CAIX, VEGF, GLUT1 and PHD3 transcript levels were quantified by reverse transcriptase-quantitative PCR and normalized to ribosomal L28 mRNA. Data are mean values±s.e.m. of n ¼ 3 independent experiments. (d) HeLa cells were transfected with pH3SVL as well as pRL-SV40, and in addition, with PHD2, control or Cdr2 siRNA oligonucleotides. Data are mean values ± s.e.m. of n ¼ 3 independent experiments performed in triplicates. Endogenous Cdr2, PHD2, HIF-1a and b-actin protein levels were analysed by immunoblotting. P-values were obtained by unpaired t-tests (*Po0.05; **Po0.01).
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Cdr2-mediated effect was PHD1 dependent (Figure 4d) . Similarly, induction of HIF-dependent reporter gene activity by siRNA-mediated Cdr2 downregulation is also dependent on PHD1 (Figure 4e ).
Cdr2 represses HIF-1 transactivation activity by interfering with p300 recruitment We next examined whether Cdr2 might also interfere with HIF-1 transactivation activity. HIF-1a contains two transactivation domains (TAD) involved in the recruitment of general transcriptional co-activators, namely, an N-terminal TAD that overlaps with the oxygen-dependent degradation domain and a C-terminal TAD (C-TAD) (Figure 5a ) (Jiang et al., 1997; Pugh et al., 1997) . Using G4-DBD fusions with HIF-1a fragments containing either the N-or C-TAD in mammalian one-hybrid experiments, we observed that hypoxically induced C-TAD activity was significantly reduced by Cdr2 overexpression, whereas N-terminal TAD activity remained unaffected (Figure 5b ). Furthermore, HIF-1a C-TAD activity was reduced by Cdr2 in a concentration-dependent manner (Figure 5c ).
To investigate whether recruitment of the general transcriptional co-activator, p300, to the HIF-1a C-TAD is modulated by Cdr2, we performed mammalian two-hybrid experiments. HeLa cells were transiently cotransfected with G4-DBD p300 CH1 domain, VP16-AD HIF-1a CTAD and a Gal4-responsive luciferase reporter plasmid, as well as Cdr2 or lacZ expression vectors. Incubation under hypoxic conditions resulted in a twofold induction of luciferase activity, which was significantly reduced by Cdr2 overexpression (Figure 5d ). Proteasomal inhibition by MG132 has been shown to stabilize CITED2, which reduces the HIF-1 transactivation activity by interfering with the HIF1a:p300 interaction (Shin et al., 2008) , and was used as positive control. Of note, we observed no significant interaction between Cdr2 and FIH under normoxic or hypoxic conditions using mammalian two-hybrid analysis (data not shown). These results suggest that Cdr2 interferes with the recruitment of p300 by the HIF1a C-TAD. 
05). (d) Phd1
À/À mouse embryonic fibroblast (MEF) cells were transiently co-transfected with pH3SVL, lacZ, Cdr2 and/or PHD1 and cultured as in b. Luciferase activities were determined and normalized to total protein content in the lysates. Data are mean values ± s.e.m. of n ¼ 3 independent experiments (*Po0.05). (e) Phd1 þ / þ and Phd1 À/À MEF cells were first transfected with Cdr2, PHD2 or control siRNA oligonucleotides and 24 h later again with the same siRNA oligonucleotides together with pH3SVL and pRL-SV40. Data are mean values ± s.e.m. of n ¼ 3 independent experiments performed in triplicates. Endogenous PHD2 and Cdr2 protein levels were analysed by immunoblotting. P-values were obtained by unpaired t-tests (*Po0.05).
Discussion
Cerebellar degeneration-related protein 2 was identified in a search for novel PHD1-interacting proteins, and comprehensive analysis of human tumor tissues revealed very strong Cdr2 protein expression in the papillary subtype of RCC. High Cdr2 protein levels correlated with strongly attenuated expression of HIF target genes in these solid tumors. Similarly, Cdr2 overexpression in different tumor cell lines reduced HIF-dependent transcriptional regulation, possibly because of both regulation of PHD1 protein expression and suppression of the transactivation activity of HIF-1a.
Paraneoplastic neurological degenerations are a diverse group of human neurodegenerative diseases associated with cancer and represent probably the most evident examples of tumor immunity in humans (Darnell and Posner, 2003a; Albert and Darnell, 2004) . It has been suggested that paraneoplastic cerebellar degeneration is initiated when the neuron-specific protein, Cdr2, is aberrantly expressed in breast and ovarian tumors, and thereby recognized as foreign tumor antigen (Darnell and Posner, 2003b) . Paraneoplastic cerebellar degeneration patients typically lack neoplastic symptoms and the disease only becomes evident when Cdr2-specific immune cells, mainly CD8 þ T cells, overcome immune tolerance in the brain and recognize neuronal Cdr2. Evidence for anti-tumor immune responses is supported by the fact that paraneoplastic cerebellar degeneration patients show 530À778 or pGH1a 786À826 expression vectors (b), or with pGH1a 786À826 alone (c), the Gal4-response element driven firefly luciferase reporter, pGRE5xE1b, and a Renilla luciferase control vector, as well as with Cdr2 expression plasmids and lacZ control vectors (c). At 24-h post-transfection, the cells were cultured under either normoxic or hypoxic conditions for an additional 16 h, and firefly luciferase activities were determined and normalized to Renilla luciferase activity. Expression of the transfected Cdr2 was verified by immunoblotting against V5, and b-actin served as loading control. (d) HeLa cells were transiently co-transfected with pG4CH1 (residues 300-523 of p300), pVP16H1a
723À826 and with Cdr2 expression plasmids, as indicated. At 24-h post-transfection, cells were cultured under normoxic or hypoxic conditions for 8 h in the presence or absence of 5 mM MG132. Luciferase activities were determined and normalized to total protein content in the lysates. Hypoxic HIF-1a accumulation and overexpression of the transfected Cdr2 were verified by immunoblotting against HIF-1a, V5 and b-actin. Results are mean values of relative luciferase activities±s.e.m. of at least n ¼ 3 independent experiments. P-values were obtained by unpaired t-tests (*Po0.05).
clinical and pathological signs of suppression of tumor growth compared with other breast and ovarian cancer patients (Peterson et al., 1992; Albert et al., 2000) . Furthermore, Santomasso et al. (2007) recently cloned the T-cell receptor genes from Cdr2-specific T lymphocytes. Subsequent expression in normal T cells transformed them into reactive cytotoxic T cells, able to lyse Cdr2-expressing human gynecological tumor cells (Santomasso et al., 2007) . Cdr2 can be considered as an important tumor antigen, as Cdr2 protein was detected in 25% of breast and 60% of ovarian tumors from patients who did not develop neurological disorders , suggesting that neoplastic Cdr2 protein expression and development of Cdr2-specific immune cells might be independent of autoimmune responses. Therefore, a functional monoclonal anti-Cdr2 antibody might be of diagnostic importance for the detection of Cdr2 in human breast and ovarian tumors, and might enable the development of an onconeural antigen-specific T-cell receptor-based therapy.
Our findings indicate that Cdr2 represents an important tumor antigen also for pRCC, as 54.2% of these tumors showed strong Cdr2 protein staining compared with 7.8% of ccRCC, and with none of chromophobe RCC or oncocytoma (Table 1) . With 10% of all RCCs, pRCC represents the most frequent RCC subtype after ccRCC (80%) (Motzer et al., 1996; Kovacs et al., 1997) . Although deletion on chromosome 3 with the VHL gene residing on 3p25 has been clearly linked to ccRCC, genetic heterogeneity in pRCC is diverse, often involving chromosomal trisomies/tetrasomies in chromosome 7 and 17, as well as losses of chromosome Y (reviewed by Moch and Mihatsch, 2002) . Cdr2 is localized on 16p12.3 and genetically not linked to pRCC.
Early signs of developing RCC are often absent and result in a high proportion of patients with metastases: 90-95% of these patients die within 5 years of diagnosis (Kosary and McLaughlin, 1993) . Therefore, early detection of tumors is crucial and Cdr2 might become of diagnostic importance as novel pRCC tumor marker. In this regard, it will be important to determine whether anti-Cdr2 antibodies and/or Cdr2 proteins are present in the serum of these patients. Interestingly, cellular host immunity has been suggested to be important in regulating tumor growth, because of late relapses after nephrectomy, sustained stabilization without systemic treatment and rare spontaneous regressions (Oliver et al., 1989; Vogelzang et al., 1992) .
Only 7.8% of ccRCC showed strong Cdr2 staining and there was no correlation to an attenuated HIF response in theses tumors (data not shown). This might be because of the fact that 71% ccRCC were characterized by loss of VHL and a constitutive active HIF response pathway, leading to a proangiogenic state. In contrast, a recent examination of 791 RCC patients by angiography showed that pRCCs were the most frequent hypovascular or avascular renal tumors (Onishi et al., 2002) . We found no evidence for a non-functional HIF signaling system in pRCC, but hypothesize that a strong Cdr2 protein expression in these tumors, resulting in increased PHD1, decreased HIF-1a, and hence suppressed activation of HIF target genes, might contribute to hypovascularization. Although pRCC is not a homogenous cancer, no difference in Cdr2 protein levels was observed between papillary type 1 and type 2 RCC, and the pathophysiological significance of Cdr2 protein expression in relation to the different pRCC types remains to be determined.
We showed that Cdr2 decreased HIF-dependent reporter as well as HIF target gene induction by suppressing both hypoxic HIF-1a protein accumulation and HIF transactivation activity. Similarly, siRNA-mediated Cdr2 downregulation increased HIF-dependent reporter gene activity. Although PHD2 is generally considered to be mainly responsible for the normoxic turnover of HIF-a protein (Berra et al., 2003; Takeda et al., 2006) , Erez et al. (2003) recently showed that overexpression of PHD1 in colon carcinoma cells inhibits tumor growth in nude mice. Increased PHD1 protein levels by Cdr2 overexpression might suggest that Cdr2 indirectly regulates HIF-1a protein abundance by elevating PHD1 levels.
Overexpression of Cdr2 also suppressed the transactivation activity of G4HIF-1a 786-826, possibly by interfering with p300 recruitment. Oxygen-dependent HIF-1a asparaginyl residue 803 (N803) hydroxylation regulates HIF transcriptional activity by regulating p300/ CBP recruitment. Cdr2 did not interact with FIH (data not shown) and it remains to be further investigated whether N803 is pivotal for HIF transactivation regulation by Cdr2. Interestingly, ectopic PHD2 expression in VHL-deficient cells has recently been shown to suppress HIF-1a transcriptional activity under hypoxic conditions without altering HIF-1a protein stability (To and Huang, 2005) . Likewise, the candidate tumor suppressor protein inhibitor of growth family member 4 (ING4) has recently been shown to associate with PHDs and affect HIF transactivation activity thereby regulating tumor growth and angiogenesis (Ozer et al., 2005) .
Taken together, we show that strong Cdr2 protein expression is specific for the papillary RCC subtype, leads to attenuation of the hypoxic response pathway, probably by regulation of PHD1 protein abundance as well as HIF transactivation activity, and propose Cdr2 as novel cancer tumor antigen for pRCC.
Materials and methods

Plasmids
Cloning work was carried out using Gateway technology (Invitrogen, Basel, Switzerland) . Cloning of PHD 1 to 3 vectors was previously described (Barth et al., 2007) . Entry vectors were generated by cloning PCR fragments into NcoI/ XhoI-digested pENTR4 (all restrictions enzymes were purchased from MBI Fermentas, Labforce, Nunningen, Switzerland). Full-length Cdr2 (residues 1 to 454) was amplified by PCR, digested with NcoI/XhoI and cloned into pENTR4. The N-terminal Cdr2 fragment (residues 1 to 208) was cloned by PvuII/NcoI digestion of pENTR4-Cdr2. The inserts of the entry vectors were verified by DNA sequencing (Microsynth, Balgach, Switzerland). ) cells were cultured in high-glucose Dulbecco's modified Eagle's medium (Sigma, Buchs, Switzerland), as described previously (Camenisch et al., 1999) . For long-term hypoxia, cells were grown in a gas-controlled glove box (InvivO 2 400, Ruskinn Technologies, Leeds, UK). Transient transfections were performed using the polyethylenimine (Polysciences, Warrington, PA, USA) method (Stiehl et al., 2006) .
Immunoblotting
Immunoblot analyses were performed as previously described (Martin et al., 2005) . Protein concentrations were determined by the Bradford method. Antibodies used were mouse mAb anti-HIF-1a (Transduction Laboratories, BD Biosciences, Allschwil, Switzerland), mAbs anti-Cdr2 (Supplementary Figure S2) , antimouse Cdr2 (Abcam, Cambridge, UK), mAb anti-V5 (Invitrogen), mAb anti-myc (Roche diagnostics, Rotkreuz, Switzerland), mAb anti-b-actin (Sigma), rabbit polyclonal anti-PHD2 antibody (Novus, Abcam, Cambridge, UK), anti-mouse PHD2 (Novus), secondary polyclonal goat anti-mouse and anti-rabbit antibodies coupled to horseradish peroxidase (Pierce, Perbio, Lausanne, Switzerland). Chemiluminescence detection was performed using Supersignal West Dura (Pierce), and signals were recorded with a charge-coupled device camera (Lightimager LAS-4000 mini, Fujifilm, Bucher Biotec, Basel, Switzerland) or by exposure to X-ray film (Fujifilm, Dielsdorf, Switzerland).
Co-immunoprecipitation
HeLa cells were co-transfected with full-length or deletion constructs of pcDNA3.1/V5-Cdr2 and pcDNA3.1/myc-PHD1, and co-immunoprecipitation experiments were done as previously described (Barth et al., 2007) .
Reporter gene and mammalian one-and two-hybrid assays Cloning of the HIF-dependent firefly luciferase reporter gene constructs pGLTfHBSww, pGLTfHBSmm and pH3SVL was described previously (Rolfs et al., 1997; Wanner et al., 2000) . Cells were co-transfected with 500 ng pH3SVL and 20 ng pRLSV40 Renilla luciferase reporter vector (Promega, Madison, WI, USA) to control for differences in transfection efficiency. At 16-h post-transfection, cells were equally distributed and exposed to 20% or 0.2% oxygen for another 16 h. After washing with PBS and carrying out cell lysis using passive cell lysis buffer (Promega), luciferase reporter gene activity was determined using the dual-luciferase reporter assay system according to the manufacturer's instructions (Promega). Mammalian one-and two-hybrid analyses were performed using the mammalian Matchmaker system (Clontech, BD Biosciences, Allschwil, Switzerland), as previously described (Barth et al., 2007) . mRNA quantification Total cellular RNA was extracted as described previously (Barth et al., 2007) and total tissue RNA was extracted using RNeasy Mini Kit (Qiagen, Hombrechtikon, Switzerland). First-strand cDNA synthesis was performed with 1-5 mg total RNA using reverse transcriptaseenzyme and mRNA levels were measured by real-time quantitative PCR using a SybrGreen qPCR reagent kit (Sigma) in combination with the MX3000P light cycler (Stratagene, Amsterdam, The Netherlands). Initial template concentrations of each sample were calculated by comparison with serial dilutions of a calibrated standard. To verify RNA integrity and equal input levels, ribosomal protein L28 or S12 mRNA was determined, and the data were expressed as ratios relative to L28 or S12 levels.
RNA-interference
HeLa or MEF cells were transfected with 100 nM siRNA oligonucleotides using Lipofectamine 2000 (Invitrogen). The following stealth RNA interference (Invitrogen) sequences were used: control siRNA, forward 5 0 -GCUCCGGAGAACU ACCAGAGUAUUA-3 0 ; control siRNA, reverse 5 0 -UAAUA CUCUGGUAGUUCUCCGGAGC-3 0 ; hCdr2 siRNA no. Tissue specimen and TMA construction Two different TMAs were constructed as previously described (Kononen et al., 1998) . A multitumor TMA containing 162 malignant and benign specimens from the following tissues: testis (12), placenta (4), breast (16), liver (12), lung (8), pancreas (8), ovary (8), colon (8), gastrointestinal stromal tumor (2), skin (6), brain (6), thyroid (8), uterus (8), kidney (16), bladder (8), prostate (12), tonsil (6), lymph node (8) and spleen (2). A total of 12 distinct cell lines from embryonal kidney (HEK-293-T), melanoma (HA98, HN2004, PF2000), mesothelioma (MET5A), colon cancer (SW480), renal carcinoma (786-O), lung carcinoma (H69), breast carcinoma (MCF7, SK BR7), cervix (HeLa) and prostate cancer (PC3), were also included. In addition, a TMA comprising 384 RCC and normal kidney specimens were collected from the University Hospital of Zu¨rich (Zu¨rich, Switzerland). All samples were histologically reviewed and selected for the study on the basis of hematoxylin and eosinstained tissue sections. This study was approved by the local commission of ethics (ref. number StV 38-2005) . Clinical information for the renal TMA was obtained for 331 cases. Tumors were graded according to the Thoenes grading system and histologically classified according to the World Health Organization classification (Eble et al., 2004) .
Immunohistochemistry TMA sections (2.5 mm) were transferred to glass slides followed by immunohistochemical analysis according to the Ventana automat protocols. The same antibody that was used for western blot analysis was applied for detection of Cdr2 (1:20) . Analysis was performed with a Leitz Aristoplan microscope (Leitz, Leica Microsystems, Heerbrugg, Switzerland). Pictures of RCC specimens were taken with a digital camera (JVC, Reinach, Switzerland, KY-070). The intensity of the staining was classified as follows: absent, weak, moderate, and strong staining.
Statistical analysis
Contingency table analysis, w 2 -tests, Kaplan-Meier curves and log rank tests for evaluating correlations between Cdr2 and HIF-target genes, as well as clinical parameters were calculated using StatView 5.0 (SAS, Cary, NC, USA).
